Tech Center 1700 • Art Units: 1649 1654 1675 1797
This examiner grants 51% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17409589 | METHODS OF TREATING CANCER | Non-Final OA | CITIUS PHARMACEUTICALS, INC. |
| 18278797 | Highly Potent M-CENK Cells And Methods | Non-Final OA | ImmunityBio, Inc. |
| 18026746 | METHODS OF TREATING AN INDIVIDUAL THAT HAS FAILED AN ANTI-PD-1/ANTI-PD-L1 THERAPY | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 16982333 | COMPOSITIONS AND METHODS FOR CANCER TREATMENT | Final Rejection | Dana-Farber Cancer Institute, Inc. |
| 17779499 | COMBINATION THERAPY FOR HEAD AND NECK CANCER | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 19358181 | METHODS OF TREATING TUMORS | Non-Final OA | Halozyme, Inc. |
| 17482650 | Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof | Non-Final OA | Merck Sharp & Dohme LLC |
| 17762354 | NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE | Non-Final OA | Regents of the University of Minnesota |
| 17817178 | THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 17413468 | BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES | Non-Final OA | The Arizona Board of Regents on Behalf of the University of Arizona |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy